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1. Introduction 
β-Lactams are not only the most commonly prescribed 
antibacterial agents,1 but also exhibit some other biological 
activities, for which they are considered as enzyme inhibitors,2 
potential chemo- and neurotherapeutic drugs,3 and gene 
activation agents.4 These biological activities, combined with the 
use of these products as starting materials to prepare α- and β-
amino acids, alkaloids, heterocycles, taxoids, and other types of 
compounds of biological and medicinal interest,5 provide the 
motivation to explore new methodologies for the synthesis of 
substances based on the β-lactam core. In addition, bridged 
acetals are structural units that are extensively encountered in a 
number of biologically active natural products such as attenol, 
brevicomin, cyclodidemniserinol, frontalin, multistriatin, and 
pinnatoxin A,6 and therefore, their stereocontrolled synthesis 
remains an intensive research area. On the other hand, alkyne 
chemistry has attracted considerable attention in recent years.7 In 
particular, transition metal-catalyzed intramolecular addition of 
oxygen nucleophiles across a carbon–carbon triple bond is one of 
the most rapid and convenient methods for the preparation of 
oxacycles.8–10 However, regioselectivity problems may be 
significant (endo versus exo cyclization). Following our 
commitment in β-lactams and the synthetic use of metals,11 in 
this paper we report a systematic investigation of the gold-
catalyzed cyclization of 1,2-diol- or acetonide-tethered alkynes 
that establishes a regio- and stereocontrolled versatile route to a 
variety of enantiopure tricyclic β-lactam-bridged acetals. 
Depending on the nature of the substituent on the alkyne, two 
different regioselectivities for the addition reactions are 
observed.12 Moreover, the mechanisms of the bis-oxycyclization 
reactions have additionally been investigated by a theoretical 
study. 
2. Results and discussion 
Figure 1 shows the structures of cyclization precursors. 
Precursors for the bridged ketal formation, alkynic 1,2-diols 1a–
e, 2a and 2b, dialkynic 1,2-diols 3a–d, alkynic acetonides 4a–e, 
5a and 5b, and dialkynic acetonides 6a–d, were made starting 
from imines of (R)-2,3-O-isopropylideneglyceraldehyde. 
Terminal alkynic acetonides 4a and 5a were prepared using the 
ketene-imine cyclization as we previously described.13 Terminal 
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diastereospecific catalytic bis-oxycyclization reaction in the presence of a gold/acid binary 
system. Interestingly, in contrast to the gold-catalyzed reactions of N-tethered terminal alkynes 
which lead to the corresponding 6,8-dioxabicyclo[3.2.1]octane derivatives (proximal adduct), 
the reactions of substituted alkynic diols and acetonides under identical conditions gave the 7,9-
dioxabicyclo[4.2.1]nonane derivatives (distal adducts) as the sole products, through exclusive 7-
endo/5-exo bis- oxycyclizations by initial attack of the oxygen atom to the external alkyne 
carbon. Moreover, the mildness of the method allowed the incorporation of a 1,3-diyne moiety 
as reactive partner, displaying exquisite chemoselectivity towards the internal alkynic moiety. In 
order to confirm the mechanistic proposal, labeling studies with deuterium oxide have been 
performed. Besides, density functional calculations were performed to gain insight into the 
mechanisms of the bis-oxycyclization reactions. 
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alkynes 4a and 5a were functionalized as their corresponding 
aryl alkynes 4b, 4c, and 5b or phenylbuta-1,3-diyne 4d under 
Sonogashira or Cadiot–Chodkiewicz conditions (Schemes S1 and 
S2, see Supporting Information). Methyl-substituted 
alkynyldioxolane 4e was prepared through base-promoted N-
propargylation of the NH-β-lactam 7b with 1-bromobut-2-yne. 
Starting alkynic acetonide 5c and dialkynic acetonides 6a–d were 
prepared from 3-hydroxy-β-lactams 814 using selective 
transformations of the hydroxylic group together with the 
Sonogashira protocol (Scheme S3, see Supporting Information). 
Diols 1–3 were prepared from acetonides 4–6 through acetonide 
hydrolysis (Schemes S1–S3, see Supporting Information). 
(+)-1a R = H
(–)-1b R = Ph
(+)-1c R = 2-thiophenyl
(–)-1d R = (ethynyl)benzene
(+)-1e R = Me
N
O
OH
OH
HH
MeO
R
O
O
(+)-4a R = H
(+)-4b R = Ph
(+)-4c R = 2-thiophenyl
(+)-4d R = (ethynyl)benzene
(+)-4e R = Me
N
O
H
MeO
R
(+)-5a R = H
(+)-5b R = Ph
(+)-5c R = Me
(+)-2a R = H
(+)-2b R = Ph
(+)-2c R = Me
N
O PMP
OH
OH
HH
O
R
N
O PMP
O
O
HH
O
R
(+)-6a R1 = H, R2 = H
(+)-6b R1 = H, R2 = Ph
(+)-6c R1 = Ph, R2 = Ph
(+)-6d R1 = Ph, R2 = H
N
O
O
O
HH
O
R1
R2
(–)-3a R1 = H, R2 = H
(–)-3b R1 = H, R2 = Ph
(–)-3c R1 = Ph, R2 = Ph
(–)-3d R1 = Ph, R2 = H
N
O
OH
OH
HH
O
R1
R2
 
Figure 1. Structures of alkynic 1,2-diols and alkynic acetonides 1–6. PMP = 
4-MeOC6H4. 
Our investigation began with alkynic diol 1a as model 
substrate. Attempts of the cyclization reaction of 1a using 
AgOTf, FeCl3, and [PtCl2(CH2=CH2)]2 catalysts failed. Nicely, it 
was found that [AuClPPh3]/AgOTf along with a Brønsted acid 
(PTSA) at room temperature could be an excellent cooperative 
catalytic system for this purpose (Scheme 1). However, the 
conversion to the corresponding tricyclic acetal 10 could not be 
satisfied with a Lewis acid (FeCl3) in the presence of 
Au(I)/Ag(I). Taking into account the above success, the more 
challenging bis-oxycyclization of alkynic acetonide 4a was tested 
(Table 1, Scheme 1). To prove this hypothesis, we initially 
started our investigation by using 2.5 mol% of 
Au(PPh3)Cl/AgOTf and 10 mol% of PTSA in CH2Cl2 at room 
temperature. To our disappointment, although the reaction gave 
bridged ketal 10 as the major product, it was obtained together 
with ketone 11, arising from alkyne hydration.15 Gratifyingly, 
after considerable experimentation, it was found that alkynic 
acetonide 4a on exposure to the system [AuClPPh3] (2.5 
mol%)/AgOTf (2.5 mol%)/PTSA (10 mol%)/H2O (100 mol%) in 
dichloromethane at 80oC on a sealed tube, directly afforded 
tricyclic ketal 10 through a regio- and diastereospecific 6-exo/5-
exo bis-oxycyclization (Table 1, Scheme 1). Formation of the 
undesired ketone 11 was avoided using 100 mol% of water as 
additive (Scheme 1). Probably, the presence of water favors the 
hydrolysis of intermediate 25 in the mechanistic proposal of 
Scheme 6, avoiding alkyne hydration. By contrast to the behavior 
of alkynic diol 1a, Brønsted and Lewis acid co-catalysis (PTSA 
and FeCl3) were equally effective starting from alkynic acetonide 
4a, which may point to two different pathways for the 
cyclizations of 1a and 4a. Besides, the reaction of acetonide 4a 
under gold catalysis in the absence of acid additive proceeded to 
afford the corresponding ketal 10 in just a slightly lower yield 
(Table 1, Scheme 1). Solvent screening demonstrated that 
dichloromethane was the best choice in the reaction (Table 1). 
The use of a more Lewis acidic gold salt (AuCl3) as catalyst 
alone without PTSA was also tested. Thus, we treated alkynic 
acetonide 4a with 5 mol% of AuCl3. However, acetal 10 was 
obtained in a poor 15% yield. 
 
Table 1. Selective bis(cyclization) reaction of alkynic dioxolane 4a under modified metal-catalyzed conditions.a 
catalyst (mol %) additive (mol %) time (h) acid (mol %) T (oC) solvent product yield (%) 
[PtCl2(CH2=CH2)]2 (2.5) TDMPP (5) 24 – 20 DCM 10 – 
AgOTf (5) – 24 – 20 DCM 10 – b 
FeCl3 (10) – 24 – 20 DCM 10 –  
AuCl3 (5) – 14 – 20 DCM 10 15 
[AuClPPh3]/AgOTf (2.5) – 15 PTSA (10) 20 DCM 10/11 31/27 
[AuClPPh3]/AgOTf (2.5) H2O (100) 2 – 80 DCM 10 71 
[AuClPPh3]/AgOTf (2.5) H2O (100) 48 FeCl3 (10) 80 DCM 10 50 
[AuClPPh3]/AgOTf (2.5) H2O (100) 3 PTSA (10) 80 THF 10 64 
[AuClPPh3]/AgOTf (2.5) H2O (100) 2 PTSA (10) 80 DCE 10 75 
 3 
[AuClPPh3]/AgOTf (2.5) H2O (100) 4 PTSA (10) 80 toluene 10 60 
[AuClPPh3]/AgOTf (2.5) H2O (100) 2 PTSA (10) 80 DCM 10 77 
 
a Yield of pure, isolated product with correct analytical and spectral data. PTSA = p-Toluenesulfonic acid. TDMPP = tris(2,6 dimethoxyphenyl)phosphine. DCM 
= Dichloromethane. THF = Tetrahydrofuran. DCE = 1,2-Dichloroethane. b Taking into account this result, AgOTf cannot be considered as a co-catalyst because 
its action is restricted to form the cationic gold species by anion exchange. 
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Scheme 1. Gold catalysis for the bis-cycloetherification of alkynic diol 1a 
and alkynic acetonide 4a. Synthesis of bridged hybrid β-lactam/acetal 10. 
Conditions: i) 2.5 mol% [AuClPPh3], 2.5 mol% AgOTf, 10 mol% PTSA, 
CH2Cl2, RT, 1a: 2 h; 4a: 15 h. ii) 2.5 mol% [AuClPPh3], 2.5 mol% AgOTf, 
10 mol% PTSA or FeCl3, 100 mol% H2O, CH2Cl2, sealed tube, 80 oC, PTSA: 
2 h (77% yield); FeCl3: 48 h (50% yield). iii) 2.5 mol% [AuClPPh3], 2.5 
mol% AgOTf, 100 mol% H2O, CH2Cl2, sealed tube, 80 oC, 2 h. PTSA = p-
Toluenesulfonic acid. 
Under the optimized reaction conditions, we 
investigated the generality of the gold/acid co-catalytic protocol 
for 1,2-diol- or acetonide-tethered alkynes 1–4. AgOTf cannot be 
considered a co-catalyst because its action is generally assumed 
to be restricted to form cationic gold species by anion 
exchange.16 The comparative studies of ketals formation with 
addition of PTSA demonstrated that the presence of the Brønsted 
acid gives higher yields, acting the acid additive as collaborator 
but not as a catalyst.17 Thus, the catalytic system may consist of 
[Au(OTf)PPh3], generated in situ from [AuClPPh3] and AgOTf. 
By examining the influence of the R substituents on the alkyne 
side chain, we found that substrates 1b–e and 4b–e bearing aryl, 
heteroaryl, alkynyl, or alkyl groups were smoothly transformed 
into products 12 in reasonable yields (Scheme 2). Worthy of 
note, in contrast to the gold-catalyzed reactions of terminal 
alkynic diol 1a and acetonide 4a which lead to the 6,8-
dioxabicyclo[3.2.1]octane derivative 10 (proximal adduct), the 
reactions of substituted alkynic diols 1b–e and acetonides 4b–e 
under identical conditions gave the 7,9-
dioxabicyclo[4.2.1]nonane derivatives 12a–d (distal adducts) as 
the products, through exclusive 7-endo/5-endo bis-
oxycyclizations by initial attack of the oxygen atom to the 
external alkyne carbon. Although complete conversion was 
observed by TLC and 1H NMR analysis of the crude reaction 
mixtures, some decomposition was observed on sensitive bridged 
oxacycles 12 during purification by flash chromatography, which 
may be responsible for the moderate isolated yields. The 
competition between the initial 6-exo and 7-endo oxycyclizations 
is gained by the latter, despite a priori should be energetically 
more demanding. Thus, the results presented in Schemes 1 and 2 
point that there exists a general mode of cyclization, namely the 
7-endo/5-endo bis-oxycyclization, for internal substituted alkynes 
and the 6-exo/5-endo mode is preferred for terminal alkynes.18 
The mildness of the method allowed the incorporation of a 1,3-
diyne moiety as reactive partner, displaying exquisite 
chemoselectivity towards the internal alkynic moiety, directing 
the bis-cycloetherification to the exclusive formation of tricyclic 
ketal 12c. The structure and stereochemistry of the bridged 
tricycle 12a were unequivocally established by X-ray 
crystallographic studies (Figure S1, see Supporting 
Information).19 
i) ii)
N
O
OH
OH
HH
MeO
(+)-12a (60% from diol; 63% from acetonide)
(+)-12b (52% from diol; 58% from acetonide)
(+)-12c (50% from diol; 52% from acetonide)
(+)-12d (58% from diol; 63% from acetonide)
(+)-4b R = Ph
(+)-4c R = Thp
(+)-4d R =
(+)-4e R = Me
N
O
O
O
HH
MeO
RR
Ph
(–)-1b R = Ph
(+)-1c R = Thp
(–)-1d R =
(+)-1e R = Me
Ph
N
O
HH
MeO O O
R
 
Scheme 2. Gold catalysis for the bis-cycloetherification of alkynic diols 1b–e 
and alkynic acetonides 4b–e. Synthesis of bridged hybrid β-lactam/acetals 12. 
Conditions: i) 2.5 mol% [AuClPPh3], 2.5 mol% AgOTf, 10 mol% PTSA, 
CH2Cl2, RT, 1b: 3 h; 1c: 3 h; 1d: 2 h; 1e: 3 h. ii) 2.5 mol% [AuClPPh3], 2.5 
mol% AgOTf, 10 mol% PTSA, 100 mol% H2O, CH2Cl2, sealed tube, 80 oC, 
4b: 3 h; 4c: 3 h; 4d: 2 h; 4e: 2 h. PTSA = p-Toluenesulfonic acid. Thp = 2-
Thiophenyl. 
When alkyne substituent was moved from position N1 to C3, 
as in 3,4-tethered diols 2 and acetonides 5, they furnished the 
corresponding bridged ketal systems 13 in fair yields and as only 
one isomer in their reactions with the gold catalytic system 
(Scheme 3). Significantly, both substituted and unsubtituted 
alkynes at the terminal position followed the same regiochemical 
pattern, yielding proximal adducts as sole bis-cycloetherification 
reaction products. Although we suspected that the 
regioselectivity for the substituted alkynic diols 2b and 2c and its 
corresponding dioxolanes 5b and 5c would be the same as the 
previous set of experiments for 1,4-tethered alkynyl derivatives 1 
and 4, we found that in the former case tricyclic acetals 13b and 
13c (proximal adducts) were obtained as single regio- and 
diastereomers. Thus, by using a related alkynic diol or acetonide 
homologue (2b, 2c or 5b, 5c versus 1b, 1e or 4b, 4e), the 
regioselectivity can be reversed, favoring the 7-exo/5-endo bis-
oxycyclization of the acetonide group towards the internal alkyne 
carbon (proximal adduct) over the 8-endo/5-endo bis-
oxycyclization towards the external alkyne carbon (distal 
adduct). The exclusive formation of proximal adducts 13b and 
13c when the distance between the dioxolane group and the 
alkyne moiety was increased, would be interpreted by 
considering the ring size of the intermediates (7-membered 
versus 8-membered rings). Probably, the combination of 
developing ring strain and the requirement to restrict rotations 
around flexible bonds in the bridged 8,10-
dioxabicyclo[5.2.1]decane system ensures unfavorable enthalpic 
and entropic contributions to ∆G, avoiding its formation.20 
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Scheme 3. Gold catalysis for the bis-cycloetherification of alkynic diols 2 
and alkynic acetonides 5. Synthesis of bridged hybrid β-lactam/acetals 13. 
Conditions: i) 2.5 mol% [AuClPPh3], 2.5 mol% AgOTf, 10 mol% PTSA, 
CH2Cl2, RT, 2a: 4 h; 2b: 5 h; 2c: 4 h. ii) 2.5 mol% [AuClPPh3], 2.5 mol% 
AgOTf, 10 mol% PTSA, 100 mol% H2O, CH2Cl2, sealed tube, 80 oC, 5a: 2 h; 
5b: 3 h; 5c: 3 h. PMP = 4-MeOC6H4. PTSA = p-Toluenesulfonic acid. 
 Upon further exploring the applicability of this bis-
cycloetherification reaction, in addition to mono-alkynes, bis-
alkynic diols 3 and acetonides 6 were also examined to obtain the 
corresponding tricyclic acetals, which would be formed by 
competitive cyclization of the contiguous dioxygenated 
functionality to one of the two triple bonds catalyzed by gold(I). 
Thus, we found that the reaction of bis-alkynes 3 and 6 bearing 
or not phenyl groups at the terminus of the alkyne, also 
proceeded smoothly to selectively give products 14–18 (Scheme 
4).21 During the course of this study, a remarkable substituent 
effect was discovered: the bis-oxycyclization exclusively ocurred 
at the unsubstituted alkynic side by treatment of mono-
substituted bis-alkynic acetonides 6b and 6d under gold/acid co-
catalysis. Besides, the bis-hydroalkoxylation of 1,4-tethered bis-
alkynic precursors 6b and 6c takes place preferentially or solely 
over the competitive reaction on the corresponding 3,4-tethered 
moiety. Thus, the chemoselectivity was uniformly high, being 
possible to direct the tricycle formation by the substitution. In 
agreement with above results (Scheme 1 and Scheme 2), different 
regioselectivity was observed for non-substituted alkyne 6b and 
substituted alkyne 6c.  As can be seen from Scheme 4, tricycles 
14, 16a, and 16b bearing a ketonic side-chain were also formed 
because of further gold-catalyzed hydration of the initially 
unreacted alkyne moiety.15 Similar results were obtained using 
bis-alkynic diols 3a–d.   
(+)-6b R1 = H, R2 = Ph
(+)-6c R1 = Ph, R2 = Ph
(+)-6d R1 = Ph, R2 = H
N
O
O
O
HH
O
R1
R2
i)
i)
+
(+)-6a
N
O
O
O
HH
O
(–)-14 (36%)
O
O
+
(–)-15a (29%)
O
O
(+)-16a (27%)
i)
(–)-15b (63%)
O
Ph
6b6c
O
Ph
Ph
+
(+)-17 (48%)
(+)-18 (37%)
Ph
O
(+)-16b (52%)
i)6d
N
O
O O
Me
H H
N
O
O O
Me
H H
N
O
O O
Me
H H
N
O
O
O
O
Me
H
N
O
O
O
O
Me
H
N
O
O
O
O
Me
H
N
O
O O
Ph
H H
 
Scheme 4. Gold catalysis for the bis-cycloetherification of bis-alkynic 
acetonides 6a–d. Synthesis of bridged hybrid β-lactam/acetals 14–18. 
Conditions: i) 2.5 mol% [AuClPPh3], 2.5 mol% AgOTf, 10 mol% PTSA, 100 
mol% H2O, CH2Cl2, sealed tube, 80 oC, 3 h. PTSA = p-Toluenesulfonic acid. 
Bis-cycloetherification of alkynic 1,2-diols 1–3, 
catalyzed by the gold system was not significantly less effective 
than was the gold catalysis for the bis-hydroalkoxylation of 
alkynic acetonides 4–6. Control experiments, however, ruled out 
the presence of a diol intermediate formed in the gold-catalyzed 
bis-oxycyclization of alkynic acetonides: Diol 1a did react in 
dichloromethane at 80oC on a sealed tube in the presence of 
[AuClPPh3] (2.5 mol%)/AgOTf (2.5 mol%)/FeCl3 (10 
mol%)/H2O (100 mol%) to afford a complex mixture of products, 
in which the tricyclic acetal 10 was not detected. Besides, no 
reaction occurred on heating a solution of the above diol in 
dichloromethane at 80oC in a sealed tube in the presence of 
[AuClPPh3] (2.5 mol%)/AgOTf (2.5 mol%)/FeCl3 (10 mol%). 
The fact that the reaction of acetonide 4a catalyzed by the π-
philic gold complex [Au(OTf)PPh3] alone, in the absence of acid 
additive, proceeded to afford the corresponding ketal 10, may 
also support this order of steps: the acetal attacks the activated 
alkyne and the resulting oxonium cation then is hydrolyzed. 
A possible mechanism for the achievement of tricyclic 
ketals 12 involving a gold-based carbophilic π-acid may proceed 
through initial η2-coordination of the metal to the triple bond of 
alkynic diols 1 leading to intermediates 19. Next, 7-endo 
alkoxyauration forms intermediates 20. Vinylmetal species 20 
did not evolve through demetalation and proton transfer 
generating the methylenic oxacycle 21 and releasing the gold 
catalyst. By contrast, rearrangement of species 20 generates the 
isomeric metalaoxonium 22, enhancing the electrophilicity of the 
unsaturated moiety. Subsequent intramolecular nucleophilic 
attack of the primary alcohol to the carbonylic-like position from 
the less hindered face would form complex 23. Demetalation 
linked to proton transfer liberates adduct 12 with concomitant 
regeneration of the Au(I) species (Scheme 5). Triflate assisted 
proton transfer from intermediates 23 to the final products 12 
may also be considered. 
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Scheme 5. Mechanistic explanation for the gold-catalyzed bis-
cycloetherification of alkynic diols 1. 
A possible pathway for the gold-catalyzed alkynyldioxolane 
cyclization may initially involve the formation of a π-complex 24 
through coordination of the gold salt to the triple bond of alkynyl 
dioxolanes 1. Next, 7-endo oxymetalation forms enol vinylmetal 
species 25. Intermediates 25 did evolve to species 22 through 
acetonide hydrolysis and further isomerization; thus, enhancing 
 5 
the electrophilicity of the resulting moiety. Subsequent 
intramolecular nucleophilic attack of the primary alcohol to the 
electrophilic position would form complex 23. Demetalation 
linked to proton transfer liberates adduct 12,22 closing the 
catalytic cycle and releasing the metal catalyst (Scheme 6). 
In order to confirm the mechanistic proposal of Scheme 6, we 
performed labeling studies with deuterium oxide. When 
alkynyldioxolane 4b was treated under bis-oxycyclization 
conditions employing D2O (200 mol%) instead of H2O, adduct 
12a with incorporation of two deuterium atoms at the methylenic 
group was achieved (Scheme 7). This double deuteration caused 
both the modification of the peaks at 3.10 and 3.87 ppm, which 
are the signals of the NCHH protons, and the disappearance of 
the peaks at 1.94 and 2.34 ppm, which are the signals of the 
NCH2CHH protons, on the 7,9-dioxabicyclo[4.2.1]nonane 12a. 
Deuterium labelling experiment starting from diol 1 was also 
accomplished, showing a similar trend to that is observed starting 
from acetonide 4 (Scheme 7). The fact that the gold-catalyzed 
conversion of alkynyldioxolane 4b into tricycle 12a in the 
presence of 2 equiv of D2O afforded double deuterated product 
[D]-12a as judge by 1H NMR spectroscopy and mass 
spectrometry (see Supporting Information), suggests that 
deuteration of the double bond in species 25 as well as 
deuterolysis of the carbon–gold bond in intermediate [D]-23 have 
occurred (Scheme S4, see Supporting 
Information).
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Scheme 6. Mechanistic explanation for the gold-catalyzed bis-
cycloetherification of alkynic acetonides 4. 
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Scheme 7. Au(I)-catalyzed bis-oxycyclization reactions of alkynyldiol and 
alkynyldioxolane derivatives 1b and 4b in presence of D2O. 
Theoretical calculations confirm the mechanistic proposals 
shown in Schemes 5 and 6 for the gold-catalyzed bis-
oxycyclization of 1,2-diol- and acetonide-alkynes (see 
Computational Methods for details). Figures 2 and 3 display the 
Gibbs energy profiles in CH2Cl2 solution for both reactions along 
with the structure of some relevant intermediates and transition 
states (TSs), and all the optimized geometries are collected in the 
Supporting Information. For the alkynic diol 1, five reaction 
steps have been found. The first one, characterized by the TS TS-
1-19 for the Au coordination, presents a small barrier of 1.9 
kcal/mol relative to isolated reactants. From this point and along 
the whole energy profile the triflate anion is clearly separated 
from the gold(I)-phosphine moiety and from the hot reacting 
points, so it certainly should not be considered a co-catalyst of 
the process. At the TSs TS-19-20 and TS-22-23 two internal 
oxycyclizations (7-endo and 5-endo, respectively) are performed, 
with energy barriers of 17.5 and 13.3 kcal/mol measured from 
their corresponding previous intermediates. Opposite to these 
energetically smooth processes, the most demanding steps are 
those involving internal rearrangements or proton transfers, TS-
20-22-BSA and TS-23-12, with energy barriers in solution of 
38.8 and 28.8 kcal/mol, respectively, from the most stable 
previous intermediate obtained by us, 19 (14.6 kcal/mol under 
reactants). TS-20-22-BSA corresponds to the rate determining 
step of the overall reactive process collected in Scheme 5. It is 
also interesting to note that, TS-20-22-BSA, 24.2 kcal/mol above 
reactants, implies the presence of the Brønsted benzenesulfonic 
acid (BSA). In effect, according to our theoretical results the 
passage from 20 to 22, which involves a 1,3-H shift from the 
oxygen atom to the gold-linked carbon atom of the seven-
membered ring, is only energetically accessible thanks to the 
presence of BSA. When this acid is not present, we located a TS, 
TS-20-21’ (49.3 kcal/mol above the intermediate 19), for a 1,2-H 
migration from the oxygen atom to the carbon atom bearing the 
R1 = H substituent. This TS evolves to a minimum energy 
structure, 21’ (–17.6 kcal/mol relative to isolated reactants), 
which would not lead to the formation of product 12. A bis-
oxycyclization has happened at 21’, but the formation of product 
12 does not occur because at 21’ both oxygen atoms bond to 
different C atoms. On the other hand, 21’ is different from 
structure 21 proposed in Scheme 5. Therefore, our theoretical 
results clearly show the crucial role played by the Brønsted acid 
in the bis-oxycyclization of 1. 
For the reaction of alkynic acetonides 4, the first step is also 
the gold coordination to the triple C–C bond, characterized by 
TS-4-24, which connects a loose initial complex (2.2 kcal/mol 
under reactants) with a tighter one (9.8 kcal/mol under reactants). 
TS-24-25 performs the first 7-endo internal cyclization, with an 
energy barrier of 13.3 kcal/mol from its previous intermediate, to 
form the enol vinylmetal species named 25a in Figure 3 (1.4 
kcal/mol under reactants). Once again the triflate anion is 
relatively far from both the gold(I)-phosphine moiety and the hot 
reacting points. No diol intermediates have been theoretically 
located before the first cyclization along the bis-oxycyclization of 
4,23 as 24 evolves to the cyclic intermediate 25a, where one of the 
C–O bonds in the acetonide ring is elongated. To go step forward 
along the reaction profile the explicit inclusion of three water 
molecules is needed, so intermediate 25a becomes 25b when 
those water molecules are added. This addition definitely breaks 
the acetonide ring and provokes the necessary rearrangements to 
facilitate the subsequent hydrolysis performed by water 
molecules. TS-25-22.1 and TS-25-22.2 represent the two 
reaction steps involved in the addition of one water molecule to 
the system along with the elimination of dimethyl ketone. At TS-
25-22.1 a water molecule is added to the double bond bearing the 
gold catalyst and at TS-25-22.2 an OH– group bonds to the C 
atom external to the seven-membered ring, while dimethyl kenote 
Tetrahedron 6 
leaves. Between both TSs we located a stable intermediate I-25-
22, 22.4 kcal/mol under reactants. TS-25-22.1 and TS-25-22.2, 
are 25.2 and 3.8 kcal/mol over reactants energy, respectively. TS-
25-22.1 corresponds to the rate-limiting step of the overall 
process shown in Scheme 6 with a value of 35.0 kcal/mol 
measured from the most stable previous intermediate, 24. This 
value is similar to that found for reactant 1, in accordance with 
the similar reaction times experimentally observed when 1 is 
allowed to react in presence of PTSA and 4 in presence of water, 
as considered in our calculations. TS-25-22.2 straight yields a 
water adduct of 22, 22b in Figure 3, without the releasing of the 
gold catalyst. Eventually, evolution from 22 to the final product 
12 goes through the same two final steps as for diol 1, those 
described by TS-22-23 and TS-23-12.
 
 
Figure 2. Gibbs energy profile in CH2Cl2 solution obtained for the gold-catalyzed bis-cyclization of the alkynic 1,2-diols 1 at the M06/6-31+G(d) (def2-SVP for 
Au) theory level. All the energies are referred to the reactants: alkynic 1,2-diol (1a) + [Au(OTf)PH3] + benzenesulfonic acid (BSA). 
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Figure 3. Gibbs energy profile in CH2Cl2 solution obtained for the gold-catalyzed bis-cyclization of the alkynic acetonides 4 at the M06/6-31+G(d) (def2-SVP 
for Au) theory level. All the energies are referred to the reactants: alkynic acetonide (4a) + [Au(OTf)PH3] + water molecules when necessary. 
 
3. Conclusions 
In conclusion, we have developed efficient catalytic systems 
based on precious metal salts for the synthesis of a variety of 
enantiopure tricyclic β-lactam-fused acetals, through regio- and 
stereocontrolled bis-oxycyclization reactions. The addition of a 
catalytic amount of PTSA to the gold catalyst improves the 
cyclo-ketalization acting the acid additive as collaborator. 
Besides, the mildness of the method allowed the incorporation of 
a 1,3-diyne moiety as reactive partner, displaying exquisite 
chemoselectivity towards the internal alkynic moiety. The 
mechanistic proposal was confirmed by labeling studies with 
deuterium oxide. Moreover, theoretical calculations are in 
agreement with the mechanistic explanations. 
4. Computational Methods 
The computational investigation was carried out with the 
simplified species Au(OTf)PH3 and benzenesulfonic acid (BSA), 
which were chosen to mimic the Au(OTf)PPh3 catalyst and the 
PTSA Brønsted acid experimentally used, respectively. These 
simplifications not only minimize the computational time but 
also make possible computations involving the catalyst and/or the 
Brønsted acid linked to the alkynic reagents without any 
significant changes in the obtained theoretical results. In 
particular, a recent theoretical study on the hydroamination of 
alkenes catalyzed by gold(I)-phosphine has proved the adequacy 
of replacing the PPh3 ligand by the PH3 one.24 Besides, the 
Brønsted acid theoretically employed, BSA, reasonably 
represents the main features of the experimental one PTSA on the 
basis of similar pKa values. 
All the quantum chemical computations were carried out with 
the Gaussian 09 series of programs.25 Full geometry 
optimizations of stable species and TSs were performed in the 
gas phase by employing the hybrid density functional M0626 in 
conjunction with the standard 6-31+G(d) basis set for the non-
metal atoms27 and the def2-SVP pseudopotential for the gold 
center.28 This computational scheme is strongly supported by 
similar theory levels used to investigate related gold-containing 
systems.29 Besides, relativistic calculations were done using the 
Douglas-Kroll-Hess (DKH) 2nd order scalar relativistic method30 
and the Gaussian nuclear model31 as implemented in Gaussian 
03; finding no significant changes in the relative energies 
involved in the rate determining energy barrier for the gold-
catalyzed bis-cyclization of the alkynic 1,2-diol 1 (see Table S3 
in Supporting Information). A similar result could be expected 
for the acetonide reaction. The nature of the stationary points was 
verified by analytical harmonic frequency calculations. The 
intrinsic reaction coordinate (IRC) algorithm was used to check 
the two minimum energy structures connecting each TS.32 To 
take into account condensed-phase effects, single-point 
calculations were also carried out on the gas-phase optimized 
geometries using the conductor-like polarizable continuum model 
Tetrahedron 8 
(CPCM) with the united atom-Kohm-Sham (UAKS) 
parametrization.33 A relative permittivity of 8.93 was assumed in 
the calculations to simulate dichloromethane as the solvent 
experimentally used. All energies given in the text correspond to 
the energy including the effect of the bulk solvent which was 
obtained by adding the contribution of the Gibbs energy of 
solvation to the gas-phase total energies. 
5. Experimental section 
5.1. General information 
1H NMR and 13C NMR spectra were recorded on a Bruker 
Avance AVIII-700 with cryoprobe, Bruker AMX-500, Bruker 
Avance-300, Varian VRX-300S or Bruker AC-200. NMR spectra 
were recorded in CDCl3 solutions, except otherwise stated. 
Chemical shifts are given in ppm relative to TMS (1H, 0.0 ppm), 
or CDCl3 (13C, 76.9 ppm). Low and high resolution mass spectra 
were taken on an AGILENT 6520 Accurate-Mass QTOF LC/MS 
spectrometer using the electronic impact (EI) or electrospray 
modes (ES) unless otherwise stated. IR spectra were recorded on 
a Bruker Tensor 27 spectrometer. Specific rotation [α]D is given 
in 10–1 deg cm2 g–1 at 20 °C, and the concentration (c) is 
expressed in g per 100 mL. All commercially available 
compounds were used without further purification. 
5.2. Experimental procedures 
Base-promoted reaction between propargylic bromides and 
hydroxy-β-lactams 8 or 9. General procedure for the 
synthesis of propargylic ethers 5c and 6a–d. Tetrabutyl 
ammonium iodide (31.9 mg, 0.086 mmol), 50% aqueous sodium 
hydroxide (100 mL), and propargyl bromide, 1-bromobut-2-yne, 
or (3-bromoprop-1-ynyl)benzene (13.82 mmol), were 
sequentially added at room temperature to a solution of the 
appropriate hydroxy-β-lactam 8 or 9 (8.64 mmol) in 
dichloromethane (100 mL). The reaction was stirred for 15 h and 
then water was added (50 mL), before being partitioned between  
dichloromethane and water. The aqueous phase was extracted 
with dichloromethane (3 x 50 mL), the combined organic extracts 
were washed with brine, dried (MgSO4), and concentrated under 
reduced pressure. Chromatography of the residue using ethyl 
acetate/hexanes mixtures as eluent gave analytically pure 
compounds 5 or 6. Spectroscopic and analytical data for some 
representative forms of 5 or 6 follow. 
Propargylic ether (+)-5c. From 253 mg (0.86 mmol) of 
hydroxy-β-lactam (+)-8a, and after chromatography of the 
residue using ethyl acetate/hexanes (1:2) as eluent gave the 
propargylic ether (+)-5c (240 mg, 81%) as a pale yellow solid. 
M.p. 91–93ºC. [α]D = +18.3 (c 0.4, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.62 and 6.83 (d, J = 9.0 Hz, each 2H), 4.88 (d, J 
= 5.6 Hz, 1H), 4.36 (s, 3H), 4.25 (dd, J = 8.9, 6.8 Hz, 1H), 4.18 
(m, 1H), 3.76 (m, 1H), 3.75 (s, 3H), 1.85 (t, J = 2.3 Hz, 3H), 1.51 
and 1.31 (s, each 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 
164.6, 156.2, 131.0, 119.3, 113.7, 109.5, 83.9, 78.7, 76.9, 73.7, 
66.9, 61.6, 59.1, 55.2, 26.5, 24.7, 3.5. IR (CHCl3) ν 1746, 2223 
cm–1. HRMS (ESI): calcd for [C19H23NO5]+ 345.1576, found 
345.1571. 
Propargylic ether (+)-6a. From 200 mg (0.89 mmol) of 
hydroxy-β-lactam (–)-8b, and after chromatography of the 
residue using hexanes/ethyl acetate (2:1) as eluent gave the 
propargylic ether (+)-6a (142 mg, 61%) as a colorless oil. [α]D = 
+7.5 (c 1.6, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 4.77 
(d, J = 5.1 Hz, 1H), 4.33 (t, J = 2.4 Hz, 2H), 4.29 and 3.86 (dd, J 
= 17.4, 2.5 Hz, each 1H), 4.25 (m, 1H), 4.08 (dd, J = 8.9, 6.6 Hz, 
1H), 3.80 (m, 1H), 3.71 (dd, J = 8.9, 5.0 Hz, 1H), 2.49 (t, J = 2.3 
Hz, 1H), 2.22 (t, J = 2.5 Hz, 1H), 1.42 and 1.29 (s, each 3H). 13C 
NMR (75 MHz, CDCl3, 25 oC) δ 166.1, 109.6, 79.9, 78.3, 76.6, 
76.4, 75.8, 72.1, 66.5, 59.1, 58.4, 30.4, 26.7, 25.0. IR (CHCl3) ν 
3310, 1744 cm–1. HRMS (ESI): calcd for [C14H17NO4]+ 263.1158, 
found 263.1152. 
Propargylic ether (+)-6b. From 134 mg (0.44 mmol) of 
hydroxy-β-lactam (–)-9, and after chromatography of the residue 
using hexanes/ethyl acetate (3:1) as eluent gave the propargylic 
ether (+)-6b (121 mg, 66%) as a yellow oil. [α]D = +7.6 (c 0.2, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.34 (m, 2H), 7.28 
(m, 3H), 4.84 (d, J = 5.3 Hz, 1H), 4.54 and 4.04 (d, J = 17.4 Hz, 
each 1H), 4.53 (s, 2H), 4.31 (m, 1H), 4.10 (dd, J = 8.9, 6.6 Hz, 
1H), 3.85 and 3.73 (dd, J = 9.1, 5.0 Hz, each 1H), 1.42 and 1.28 
(s, each 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 166.5, 131.7, 
131.6, 128.7, 128.4, 128.3, 128.2, 122.4, 122.0, 87.4, 83.8, 83.6, 
80.0, 76.7, 66.7, 59.3, 59.2, 31.3, 26.9, 26.1. IR (CHCl3) ν 2190, 
1745 cm–1. HRMS (ESI): calcd for [C20H21NO4]+ 339.1471, 
found 339.1467. 
Propargylic ether (+)-6c. From 99 mg (0.44 mmol) of hydroxy-
β-lactam (–)-8b, and after chromatography of the residue using 
hexanes/ethyl acetate (4:1) as eluent gave the propargylic ether 
(+)-6c (96 mg, 64%) as a colorless oil. [α]D = +4.5 (c 0.2, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.45 (m, 2H), 7.33 
(m, 3H), 4.91 (m, 1H), 4.60 (s, 2H), 4.33 (m, 2H), 4.16 (m, 1H), 
3.89 (m, 2H), 3.79 (dd, J = 8.9, 5.1 Hz, 1H), 2.24 (m, 1H), 1.48 
and 1.35 (s, each 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 
166.5, 131.8, 128.7, 128.3, 122.0, 109.7, 87.4, 83.6, 80.0, 76.8, 
76.6, 72.2, 66.7, 59.3, 59.2, 30.5, 26.8, 25.1. IR (CHCl3) ν 3305, 
2194, 1745 cm–1. HRMS (ESI): calcd for [C26H25NO4]+ 415.1784, 
found 415.1788. 
Propargylic ether (+)-6d. From 114 mg (0.38 mmol) of 
hydroxy-β-lactam (–)-9, and after chromatography of the residue 
using hexanes/ethyl acetate (3:1) as eluent gave the propargylic 
ether (+)-6d (71 mg, 55%) as a yellow oil. [α]D = +5.1 (c 0.1, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.33 (m, 2H), 7.22 
(m, 3H), 4.77 (d, J = 5.3 Hz, 1H), 4.53 and 4.04 (d, J = 17.5 Hz, 
each 1H), 4.32 (t, J = 2.0 Hz, 1H), 4.28 (m, 1H), 4.07 (m, 1H), 
3.85 and 3.71 (dd, J = 9.1, 5.0 Hz, each 1H), 2.44 (t, J = 2.3 Hz, 
1H), 1.43 and 1.28 (s, each 3H). 13C NMR (75 MHz, CDCl3, 25 
oC) δ 166.3, 131.7, 128.5, 128.2, 122.4, 109.7, 83.9, 82.1, 79.9, 
78.4, 76.6, 75.8, 66.6, 59.1, 58.5, 31.4, 27.0, 25.2. IR (CHCl3) ν 
3300, 2190, 1742 cm–1. HRMS (ESI): calcd for [C20H21NO4]+ 
339.1471, found 339.1473. 
Palladium-catalyzed reaction between iodoarenes and 
terminal alkynes (+)-4a, (+)-5a, and (–)-8. General procedure 
for the synthesis of aryl-substituted alkynes (+)-4b, (+)-4c, 
(+)-5b, and (–)-9. PdCl2(PPh3)2 (7 mg, 0.01 mmol), CuI (3.8 mg, 
0.02 mmol), and triethylamine (60.6 mg, 0.6 mmol) were 
sequentially added to a solution of the corresponding terminal 
alkyne 4, 5, or 8 (1.0 mmol) and the appropriate iodoarene (1.0 
mmol) in acetonitrile (0.8 mL), under argon atmosphere. The 
reaction mixture was stirred at room temperature. After 
completion of the reaction as indicated by TLC, the mixture was 
poured into water (5 mL) and extracted with ethyl acetate (3 x 
5 mL). The organic layer was washed with water (2 x 10 mL) and 
brine (2 x 10 mL), dried over MgSO4, and concentrated under 
reduced pressure. Chromatography of the residue eluting with 
hexanes/ethyl acetate mixtures gave analytically pure aryl-
substituted alkynes 4, 5, and 9. 
Phenyl-substituted alkyne (+)-4b. From 261 mg (1.09 mmol) of 
terminal alkyne (+)-4a, and after chromatography of the residue 
using hexanes/ethyl acetate (3:1) as eluent gave the phenylprop-
2-ynyl dioxolane (+)-4b (235 mg, 68%) as a pale yellow solid. 
M. p. 83–85 oC. [α]D = +2.3 (c 0.7, CHCl3). 1H NMR (300 MHz, 
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CDCl3, 25 oC) δ 7.33 (m, 5H), 4.59 and 4.09 (d, J = 17.3 Hz, 
each 1H), 4.45 (d, J = 5.1 Hz, 1H), 4.33 (ddd, J = 11.5, 6.6, 4.9 
Hz, 1H), 4.10 (dd, J = 8.8, 6.6 Hz, 1H), 3.85 and 3.70 (dd, J = 
9.0, 5.0 Hz, each 1H), 3.52 (s, 3H), 1.48 and 1.34 (s, each 3H). 
13C NMR (75 MHz, CDCl3, 25 oC) δ 166.7, 131.6, 128.4, 128.2, 
122.4, 109.6, 83.8, 83.1, 82.2, 76.7, 66.6, 59.2, 59.1, 31.2, 26.9, 
25.1. IR (CHCl3) ν 1745, 2220 cm–1. HRMS (ESI): calcd for 
[C18H21NO4]+ 315.1471, found 315.1468. 
2-Thiophenyl-substituted alkyne (+)-4c. From 250 mg (1.05 
mmol) of terminal alkyne (+)-4a, and after chromatography of 
the residue using hexanes/ethyl acetate (2:1) as eluent gave the 2-
thiophenylprop-2-ynyl dioxolane (+)-4c (266 mg, 79%) as a pale 
orange solid. M.p. 122–124 oC. [α]D = +1.3 (c 0.6, CHCl3). 1H 
NMR (300 MHz, CDCl3, 25 oC) δ 7.21 (dd, J = 5.1, 1.0 Hz, 1H), 
7.15 (dd, J = 3.7, 1.0 Hz, 1H), 6.92 (dd, J = 5.1, 3.7 Hz, 1H), 
4.58 and 4.09 (d, J = 17.5 Hz, each 1H), 4.44 (d, J = 5.1 Hz, 1H), 
4.30 (m, 1H), 4.10 (m, 1H), 3.82 and 3.68 (dd, J = 9.0, 5.1 Hz, 
each 1H), 3.50 (s, 3H), 1.48 and 1.32 (s, each 3H). 13C NMR (75 
MHz, CDCl3, 25 oC) δ 166.6, 132.2, 127.2, 126.8, 122.3, 109.6, 
86.2, 83.0, 77.1, 76.6, 66.5, 59.2, 59.1, 31.3, 26.9, 25.1. IR 
(CHCl3) ν 1744, 2225 cm–1. HRMS (ESI): calcd for 
[C16H19NO4S]+ 321.1035, found 321.1029. 
Phenyl-substituted alkyne (+)-5b. From 64 mg (0.19 mmol) of 
terminal alkyne (+)-5a, and after chromatography of the residue 
using hexanes/ethyl acetate (3:1) as eluent gave the phenylprop-
2-ynyl dioxolane (+)-5b (65 mg, 84%) as a yellow oil. [α]D = 
+8.2 (c 0.4, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.67 
and 6.86 (d, J = 9.0 Hz, each 2H), 7.33 (m, 3H), 5.00 (d, J = 5.6 
Hz, 1H), 4.68 (s, 2H), 4.29 (m, 3H), 3.84 (dd, J = 8.6, 5.9 Hz, 
1H), 3.78 (s, 3H), 1.53 and 1.34 (s, each 3H). 13C NMR (75 MHz, 
CDCl3, 25 oC) δ 164.6, 156.5, 131.8, 131.0, 128.8, 128.3, 119.5, 
113.9, 109.7, 87.5, 83.5, 79.0, 77.6, 67.0, 61.8, 59.4, 55.3, 26.7, 
24.9. IR (CHCl3) ν 1743, 2222 cm–1. HRMS (ESI): calcd for 
[C24H25NO5]+ 407.1733, found 407.1726. 
Phenyl-substituted alkyne (–)-9. From 338 mg (1.50 mmol) of 
terminal alkyne (–)-8, and after chromatography of the residue 
using hexanes/ethyl acetate (1:1) as eluent gave the phenylprop-
2-ynyl dioxolane (–)-9 (261 mg, 58%) as a yellow solid M.p. 
144–142ºC. [α]D = –4.3 (c 0.9, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.33 (m, 2H), 7.22 (m, 3H), 4.85 (m, 2H), 4.53 
and 4.03 (d, J = 17.5 Hz, each 1H), 4.36 (td, J = 6.9, 4.5 Hz, 1H), 
4.13 (dd, J = 9.0, 6.9 Hz, 1H), 3.85 (m, 2H), 1.42 and 1.28 (s, 
each 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 169.4, 131.6, 
128.5, 128.2, 122.2, 109.9, 84.2, 81.7, 75.7, 66.5, 60.2, 31.3, 
26.7, 25.0. IR (CHCl3) ν 1742, 2224 cm–1. HRMS (ESI): calcd 
for [C17H19NO4]+ 301.1314, found 301.1310. 
Procedure for the preparation of methyl-substituted alkyne 
(+)-4e. A solution of the NH-β-lactam (+)-(3R,4S)-4-[(S)-2,2-
dimethyl-1,3-dioxolan-4-yl]-3-methoxyazetidin-2-one34 (179 mg, 
0.89 mmol) in THF (2 mL) was slowly added to a suspension of 
sodium hydride (38 mg, 1.98 mmol) in the same solvent (10 mL) 
at 0oC. After 1h stirring at room temperature, the solution was 
cooled at 0oC and 1-bromobut-2-yne (131 mg, 0.99 mmol) was 
added. The reaction was stirred for 12 h and then NaHCO3 (aq. 
sat.) was added (1 mL), before being partitioned between  ethyl 
acetate and water. The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL), the combined organic extracts were washed 
with brine, dried (MgSO4), and concentrated under reduced 
pressure. Chromatography of the residue using ethyl 
acetate/hexanes (1:2) as eluent gave 113 mg (50%) of 
analytically pure compound (+)-4e as a pale yellow solid. M.p. 
133–134ºC.  [α]D = +21.4 (c 0.2, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 4.39 (d, J = 5.1 Hz, 1H), 4.26 (m, 2H), 4.06 (dd, 
J = 8.8, 6.6 Hz, 1H), 3.77 (m, 2H), 3.65 (dd, J = 8.8, 5.1 Hz, 1H), 
3.49 (s, 3H), 1.75 (t, J = 2.4 Hz, 3H), 1.48 and 1.30 (s, each 
3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 166.6, 109.5, 82.9, 
79.7, 76.7, 72.1, 66.6, 59.0, 30.8, 26.8, 25.1, 3.2. IR (CHCl3) ν 
1744, 2224 cm–1. HRMS (ESI): calcd for [C13H19NO4]+ 253.1314, 
found 253.1314. 
Procedure for the Synthesis of Bromoalkynyl-β-lactam (+)-
7a. To a solution of the alkynyl 2-azetidinone (+)-4a (0.37 mmol) 
in acetone (2.5 mL) were added NBS (0.094 g, 0.46 mmol) and 
silver acetate (0.019 g, 0.11 mmol). The reaction mixture was 
stirred at room temperature in the dark until disappearance (TLC) 
of the starting material. The solids were removed by filtration 
through a Celite pad (washing with ethyl acetate). The combined 
organic filtrates were washed with water and brine, dried 
(Na2SO4), concentrated under reduced pressure, and then purified 
by column chromatography eluting with ethyl acetate/hexanes 
(3/1) to give 95 mg (81%) of analytically pure bromoalkynyl-β-
lactam (+)-7a as a pale yellow oil. 
Bromoalkynyl-β-lactam (+)-7a. [α]D = +28.2 (c 0.4, CHCl3). 1H 
NMR (300 MHz, CDCl3, 25 oC) δ 4.46 (d, J = 5.1 Hz, 2H), 4.38 
and 3.92 (d, J = 17.3 Hz, each 1H), 4.30 (m, 1H), 4.11 (dd, J = 
8.8, 6.5 Hz, 1H), 3.80 and 3.70 (dd, J = 9.0, 5.0 Hz, each 1H), 
3.53 (s, 3H), 1.48 and 1.35 (s, each 6H). 13C NMR (CDCl3) δ 
166.7, 109.7, 83.1, 76.6, 73.3, 66.7, 59.5, 59.2, 43.7, 31.5, 26.9, 
25.1. IR (CHCl3) ν 1742 cm–1. HRMS (ESI): calcd for 
[C12H16BrNO4]+ 317.0263, found 317.0270. 
Copper(I) Chloride Promoted Heterocoupling Reaction 
between 2-Azetidinone-Tethered Alkyne (+)-7a and 
Phenylacetylene. Procedure for the Synthesis of 1,3-Diyne-β-
Lactam (+)-4d. Few crystals of hydroxylamine hydrochloride, a 
70% EtNH2 (0.25 mL) aqueous solution, and CuCl (0.006 mmol, 
0.002 equiv) were sequentially added at room temperature to a 
solution of the alkynyl 2-azetidinone (+)-7a (0.36 mmol) in 
methanol (1.8 mL). Then, phenylacetylene (0.36 mmol) in 
CH2Cl2 (5 mL) was added to the above acetylide suspension 
cooled at 0oC. More crystals of hydroxylamine hydrochloride 
were added throughout the reaction as necessary to prevent the 
solution from turning blue or green. The reaction mixture was 
stirred until disappearance (TLC) of the starting materials. The 
products were extracted with ethyl acetate (3 × 5 mL), dried over 
MgSO4, and concentrated under reduced pressure. Purification by 
column chromatography eluting with ethyl acetate/hexanes (1/3) 
to give 118 mg (97%) of analytically pure 1,3-diyne-β-lactam 
(+)-4d as a pale yellow oil. 
1,3-Diyne-β-Lactam (+)-4d. [α]D = +0.78 (c 0.2, CHCl3). 1H 
NMR (300 MHz, CDCl3, 25 oC) δ 7.49 (m, 2H), 7.35 (m, 3H), 
4.54 and 4.06 (d, J = 18.0 Hz, each 1H), 4.49 (d, J = 5.1 Hz, 1H), 
4.33 (m, 1H), 4.13 (dd, J = 9.0, 6.6 Hz, 1H), 3.86 and 3.72 (dd, J 
= 9.0, 5.1 Hz, each 1H), 3.55 (s, 3H), 1.52 and 1.37 (s, each 3H). 
13C NMR (75 MHz, CDCl3, 25 oC) δ 166.7, 132.6, 129.3, 128.4, 
121.3, 109.8, 83.2, 77.3, 76.6, 75.9, 73.3, 68.7, 66.6, 59.5, 59.2, 
31.4, 26.9, 25.2. IR (CHCl3) ν 1743, 2195 cm–1. HRMS (ESI): 
calcd for [C20H21NO4]+ 339.1471, found 339.1466. 
General Procedure for the Preparation of 2-Azetidinone-
Tethered Alkynic Diols 1a–e, 2a, 2b, and 3a–d. To a solution 
of the corresponding acetonide β-lactam (10 mmol) in THF/water 
(1:1, 200 mL) was added solid p-TsOH.H2O (12 mmol) in a 
single portion. The resulting clear solution was heated under 
reflux for 2h. The reaction mixture was allowed to cool to room 
temperature, and then was neutralized with solid NaHCO3. The 
mixture was extracted with ethyl acetate (3 x 40 mL), the organic 
layer was dried (MgSO4) and the solvent was removed under 
reduced pressure to give diols 1–3. Further purification was not 
Tetrahedron 10 
necessary. Spectroscopic and analytical data for some 
representative forms of 1–3 follow. 
Alkynic Diol (+)-1a. From 220 mg (0.92 mmol) of dioxolane 
(+)-4a, diol (+)-1a (183 mg, quantitative yield) was obtained as a 
yellow oil. [α]D = +0.2 (c 1.0, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 4.52 (d, J = 4.9 Hz, 1H), 4.36 (dd, J = 17.5, 2.5 
Hz, 1H), 4.00 (m, 2H), 3.92 (m, 2H), 3.70 (m, 2H), 3.60 (s, 3H), 
3.07 and 2.59 (br s, each 1H), 2.31 (t, J = 2.4 Hz, 1H). 13C NMR 
(75 MHz, CDCl3, 25 oC) δ 167.0, 83.3, 72.8, 70.8, 63.9, 59.5, 
58.1, 31.0. IR (CHCl3) ν 3450, 1744, 2180 cm–1. HRMS (ESI): 
calcd for [C9H13NO4]+ 199.0845, found 199.0851. 
Alkynic Diol (–)-1b. From 199 mg (0.59 mmol) of dioxolane 
(+)-4b, diol (–)-1b (162 mg, quantitative yield) was obtained as 
colorless solid. M.p. 102–104ºC. [α]D = –0.4 (c 0.6, CHCl3). 1H 
NMR (300 MHz, CDCl3, 25 oC) δ 7.34 (m, 5H), 4.55 and 4.14 (d, 
J = 18.0 Hz, each 1H), 4.49 (d, J = 4.9 Hz, 1H), 4.01 (m, 1H), 
3.96 (dd, J = 9.5, 4.6 Hz, 1H), 3.71 (m, 2H), 3.57 (s, 3H), 3.21 
(br s, 2H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 167.1, 131.7, 
128.6, 128.3, 122.0, 84.5, 83.3, 81.9, 70.9, 63.9, 59.4, 58.0, 31.8. 
IR (CHCl3) ν 3445, 1742, 2185 cm–1. HRMS (ESI): calcd for 
[C15H17NO4]+ 275.1158, found 275.1162. 
Alkynic Diol (+)-1c. From 141 mg (0.44 mmol) of dioxolane 
(+)-4c, diol (+)-1c (124 mg, quantitative yield) was obtained as 
yellow oil. [α]D = +2.3 (c 0.1, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.22 (dd, J = 5.1, 1.0 Hz, 1H), 7.18 (dd, J = 3.7, 
1.0 Hz, 1H), 6.93 (dd, J = 5.1, 3.7 Hz, 1H), 4.57 and 4.15 (d, J = 
17.8 Hz, each 1H), 4.49 (d, J = 4.9 Hz, 1H), 3.99 (m, 1H), 3.92 
(t, J = 4.9 Hz, 1H), 3.69 (m, 2H), 3.56 (s, 3H), 3.20 (br s, 2H). 
13C NMR (75 MHz, CDCl3, 25 oC) δ 167.1, 132.5, 127.4, 126.9, 
121.9, 86.0, 83.3, 77.7, 71.0, 63.9, 59.4, 58.0, 31.9. IR (CHCl3) ν 
3440, 1744, 2180 cm–1. HRMS (ESI): calcd for [C13H15NO4S]+ 
281.0722, found 281.0717. 
Alkynic Diol (–)-1d. From 55 mg (0.16 mmol) of dioxolane (+)-
4d, diol (–)-1d (48 mg, quantitative yield) was obtained as 
yellow oil. [α]D = –1.9 (c 1.1, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.50 (m, 2H), 7.34 (m, 3H), 4.57 (d, J = 5.1 Hz, 
1H), 4.55 and 4.12 (d, J = 12.2 Hz, each 1H), 4.05 (m, 1H), 3.98 
(m, 1H), 3.82 (m, 1H), 3.73 (dd, J = 6.0, 4.7 Hz, 1H), 3.63 (s, 
3H), 2.89 (br s, 2H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 166.8, 
132.6, 129.5, 128.4, 83.6, 77.7, 75.5, 73.1, 70.6, 69.2, 64.0, 59.6, 
58.3, 32.0. IR (CHCl3) ν 3450, 1743, 2175 cm–1. HRMS (ESI): 
calcd for [C17H17NO4]+ 299.1158, found 299.1166. 
Alkynic Diol (+)-1e. From 66 mg (0.16 mmol) of dioxolane (+)-
4e, diol (+)-1e (55 mg, quantitative yield) was obtained as 
colorless oil. [α]D = +4.6 (c 0.7, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 4.48 (d, J = 5.1 Hz, 1H), 4.25 and 3.87 (dq, J = 
17.4, 2.3 Hz, each 1H), 3.98 (m, 1H), 3.88 (t, J = 5.0 Hz, 1H), 
3.68 (m, 2H), 3.57 (s, 3H), 3.16 and 2.78 (br s, each 1H), 1.79 (t, 
J = 2.4 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 167.0, 83.2, 
80.7, 72.0, 71.0, 63.9, 59.4, 58.0, 31.4, 3.3. IR (CHCl3) ν 3454, 
1745, 2215 cm–1. HRMS (ESI): calcd for [C10H15NO4]+ 213.1001, 
found 213.1009. 
Alkynic Diol (+)-2a. From 266 mg (0.80 mmol) of dioxolane 
(+)-5a, diol (+)-2a (233 mg, quantitative yield) was obtained as 
yellow oil. [α]D = +1.0 (c 0.7, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.37 and 6.80 (d, J = 9.0 Hz, each 2H), 4.89 (d, J 
= 5.4 Hz, 1H), 4.42 (m, 2H), 4.35 (m, 1H), 4.08 (m, 2H), 3.72 (s, 
3H), 3.60 (d, J = 5.6 Hz, 1H), 3.34 (br s, 2H), 2.57 (t, J = 2.5 Hz, 
1H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 164.8, 156.6, 130.6, 
119.9, 114.0, 79.5, 78.3, 76.4, 76.3, 71.3, 63.4, 58.9, 55.3. IR 
(CHCl3) ν 3442, 1744, 2172 cm–1. HRMS (ESI): calcd for 
[C15H17NO5]+ 291.1107, found 291.1110. 
Alkynic Diol (+)-2b. From 162 mg (0.40 mmol) of dioxolane 
(+)-5b, diol (+)-2b (147 mg, quantitative yield) was obtained as 
colorless oil. [α]D = +14.9 (c 0.9, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.39 (m, 7H), 6.82 (d, J = 9.0 Hz, 2H), 4.99 (d, J 
= 5.4 Hz, 1H), 4.66 (d, J = 2.0 Hz, 2H), 4.39 (t, J = 4.9 Hz, 1H), 
4.17 (m, 1H), 3.73 (s, 3H), 3.65 (d, J = 5.9 Hz, 2H), 2.96 (br s, 
2H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 164.9, 156.6, 131.7, 
130.7, 128.8, 128.3, 121.8, 120.0, 114.1, 87.8, 83.4, 79.7, 71.4, 
63.5, 59.8, 58.4, 55.3. IR (CHCl3) ν 3435, 1745, 2175 cm–1. 
HRMS (ESI): calcd for [C21H21NO5]+ 367.1420, found 367.1414. 
Alkynic Diol (+)-2c. From 120 mg (0.35 mmol) of dioxolane 
(+)-5c, diol (+)-2c (107 mg, quantitative yield) was obtained as 
colorless oil. [α]D = +36.9 (c 0.1, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.38 and 6.83 (d, J = 9.0 Hz, each 2H), 4.96 (d, J 
= 5.4 Hz, 1H), 4.42 (m, 3H), 4.18 (m, 1H), 3.76 (s, 3H), 3.75 (m, 
1H), 3.64 (d, J = 6.1 Hz, 1H), 3.12 and 2.68 (br s, each 1H), 1.87 
(t, J = 2.3 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 165.0, 
156.6, 130.7, 119.9, 114.1, 84.6, 79.5, 73.7, 71.3, 63.5, 59.7, 
58.3, 55.4, 3.6. IR (CHCl3) ν 3435, 1745, 2175 cm–1. HRMS 
(ESI): calcd for [C16H19NO5]+ 305.1263, found 305.1257. 
Alkynic Diol (–)-3a. From 56 mg (0.21 mmol) of dioxolane (+)-
6a, diol (–)-3a (47 mg, quantitative yield) was obtained as yellow 
oil. [α]D = –5.5 (c 0.2, CHCl3). 1H NMR (300 MHz, CDCl3, 25 
oC) δ 4.85 (d, J = 5.0 Hz, 1H), 4.44 (ddd, J = 23.2, 16.0, 2.3 Hz, 
2H), 4.34 (dd, J = 13.0, 2.5 Hz, 1H), 4.05 (m, 1H), 3.97 (m, 2H), 
3.78 (dd, J = 11.5, 3.7 Hz, 1H), 3.67 (dd, J = 11.5, 6.1 Hz, 1H), 
3.13 and 2.75 (br s, each 1H), 2.55 (t, J = 2.3 Hz, 1H), 2.32 (t, J = 
2.5 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 166.6, 80.4, 
78.2, 76.8, 76.2, 72.9, 70.9, 63.8, 58.8, 58.2, 30.4, 31.2. IR 
(CHCl3) ν 3440, 3315, 1745 cm–1. HRMS (ESI): calcd for 
[C11H13NO4]+ 223.0845, found 223.0852. 
Alkynic Diol (–)-3b. From 32 mg (0.078 mmol) of dioxolane 
(+)-6b, diol (–)-3b (29 mg, quantitative yield) was obtained as 
colorless oil. [α]D = –1.2 (c 1.4, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.45 (m, 4H), 7.33 (m, 6H), 5.00 (d, J = 5.1 Hz, 
1H), 4.73 and 4.66 (d, J = 16.0 Hz, each 1H), 4.54 and 4.20 (d, J 
= 17.0 Hz, each 1H), 4.18 (m, 1H), 4.05 (t, J = 4.6 Hz, 1H), 3.83 
(m, 1H), 2.12 (br s, 1H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 
166.6, 131.9, 131.8, 128.9, 128.8, 128.4, 128.3, 122.0, 121.9, 
87.9, 84.8, 83.4, 81.8, 80.7, 70.7, 64.0, 59.8, 58.4, 32.0. IR 
(CHCl3) ν 3434, 2190, 1742 cm–1. HRMS (ESI): calcd for 
[C23H21NO4]+ 375.1471, found 375.1468. 
Alkynic Diol (–)-3c. From 56 mg (0.17 mmol) of dioxolane (+)-
6c, diol (–)-3c (51 mg, quantitative yield) was obtained as 
colorless oil; [α]D = –0.4 (c 4.3, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.44 (m, 2H), 7.31 (m, 3H), 4.94 (d, J = 5.0 Hz, 
1H), 4.69 and 4.62 (d, J = 16.0 Hz, each 1H), 4.37 and 3.97 (dd, 
J = 17.7, 2.5 Hz, each 1H), 4.11 (m, 1H), 3.96 (t, J = 5.0 Hz, 1H), 
3.81 (dd, J = 11.4, 3.8 Hz, 1H), 3.71 (dd, J = 11.4, 6.2 Hz, 1H), 
2.74 (br s, 2H), 2.32 (t, J = 2.5 Hz, 1H). 13C NMR (75 MHz, 
CDCl3, 25 oC) δ 166.8, 131.8, 128.9, 128.4, 121.9, 87.8, 83.4, 
80.5, 77.2, 76.8, 72.9, 70.8, 63.9, 59.7, 58.3, 31.1. IR (CHCl3) ν 
3442, 3300, 2192, 1740 cm–1. HRMS (ESI): calcd for 
[C17H17NO4]+ 299.1158, found 299.1162. 
Alkynic Diol (–)-3d. From 30 mg (0.088 mmol) of dioxolane 
(+)-6d, diol (–)-3d (26 mg, quantitative yield) was obtained as 
colorless oil. [α]D = –1.2 (c 1.3, CHCl3). 1H NMR (300 MHz, 
CDCl3, 25 oC) δ 7.43 (m, 2H), 7.32 (m, 3H), 4.90 (d, J = 5.0 Hz, 
1H), 4.57 and 4.19 (d, J = 17.7 Hz, each 1H), 4.43 and 4.50 (dd, 
J = 16.0, 2.3 Hz, each 1H), 4.12 (m, 1H), 4.03 (t, J = 5.0 Hz, 1H), 
3.83 (dd, J = 11.4, 4.0 Hz, 1H), 3.77 (dd, J = 11.4, 6.3 Hz, 1H), 
2.54 (t, J = 2.3 Hz, 1H), 2.18 (br s, 2H). 13C NMR (75 MHz, 
CDCl3, 25 oC) δ 166.4, 131.8, 128.8, 128.4, 122.0, 84.7, 81.8, 
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80.6, 78.2, 76.2, 70.7, 64.0, 58.9, 58.2, 32.0. IR (CHCl3) ν 3450, 
3294, 2190, 1743 cm–1. HRMS (ESI): calcd for [C17H17NO4]+ 
299.1158, found 299.1152. 
General procedure for the metal-catalyzed cyclization of 
alkynyldioxolanes 4–6 in the presence of water. Preparation 
of bridged acetals 10, and 12–18. [AuClPPh3] (0.0093 mmol), 
AgOTf (0.0093 mmol), p-toluenesulfonic acid or FeCl3 (0.037 
mmol), and water (0.37 mmol) were sequentially added to a 
stirred solution of the corresponding alkynyldioxolane 4–6 (0.37 
mmol) in dichloromethane (0.37 mL). The resulting mixture was 
heated in a sealed tube at 80 oC until disappearance of the starting 
material (TLC). The reaction was allowed to cool to room 
temperature and filtered through a pack of celite. The filtrate was 
extracted with ethyl acetate (3 x 5 mL), and the combined 
extracts were washed twice with brine. The organic layer was 
dried (MgSO4) and concentrated under reduced pressure. 
Chromatography of the residue eluting with ethyl acetate/hexanes 
mixtures gave analytically pure adducts 10, and 12–18. 
Tricyclic acetal (–)-10. From 70 mg (0.29 mmol) of 
alkynyldioxolane (+)-4a, and after chromatography of the residue 
using hexanes/ethyl acetate (1:1) as eluent gave the acetal (–)-10 
(45 mg, 77%) as a colorless oil. [α]D = –1.3 (c 0.9, CHCl3). 1H 
NMR (300 MHz, CDCl3, 25 oC) δ 4.79 and 4.66 (dd, J = 4.8, 1.2 
Hz, each 1H), 3.84 (m, 3H), 3.65 (s, 3H), 3.53 (m, 1H), 2.98 (dt, 
J = 12.9, 0.6 Hz, 1H), 1.51 (s, 3H). 13C NMR (75 MHz, CDCl3, 
25 oC) δ 173.8, 104.5, 83.9, 71.0, 69.1, 59.3, 55.4, 51.5, 22.9. IR 
(CHCl3) ν 1750, 1192, 1042 cm–1. HRMS (ESI): calcd for 
[C9H13NO4 + H]+ 200.0923, found 200.0927. 
Tricyclic acetal (+)-12a. From 49 mg (0.16 mmol) of 
alkynyldioxolane (+)-4b, and after chromatography of the residue 
using hexanes/ethyl acetate (1:1) as eluent gave the acetal (+)-
12a (26 mg, 63%) as a colorless solid. M.p. 150–152ºC. [α]D = 
+5.0 (c 1.1, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.44 
(m, 5H), 4.66 and 4.57 (d, J = 4.8 Hz, each 1H), 4.09 (m, 1H), 
4.01 (dd, J = 8.1, 4.9 Hz, 1H), 3.87 (ddd, J = 14.4, 5.4, 1.5 Hz, 
1H), 3.79 (d, J = 4.6 Hz, 1H), 3.63 (s, 3H), 3.10 (ddd, J = 14.6, 
12.0, 4.2 Hz, 1H), 2.34 (ddd, J = 14.4, 12.2, 5.4 Hz, 1H), 1.94 
(ddd, J = 14.4, 3.9, 1.0 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 
oC) δ 168.2, 142.5, 128.2, 128.1, 124.7, 111.8, 83.5, 72.2, 71.2, 
63.0, 59.2, 38.6, 36.5. IR (CHCl3) ν 1748, 1190, 1044 cm–1. 
HRMS (ESI): calcd for [C15H17NO4 + H]+ 276.1236, found 
276.1232. 
Tricyclic Acetal (+)-12b. From 118 mg (0.37 mmol) of 
alkynyldioxolane (+)-4c, and after chromatography of the residue 
using hexanes/ethyl acetate (1:1) as eluent gave the acetal (+)-
12b (60 mg, 58%) as a colorless solid. M.p. 101–103ºC. [α]D = 
+5.4 (c 3.9, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.23 
(dd, J = 5.0, 1.2 Hz, 1H), 7.09 (dd, J = 3.7, 1.2 Hz, 1H), 6.95 (dd, 
J = 5.0, 3.7 Hz, 1H), 4.72 (d, J = 5.1 Hz, 1H), 4.55 and 3.77 (d, J 
= 4.7 Hz, each 1H), 4.19 (dd, J = 8.0, 5.1 Hz, 1H), 4.08 (m, 1H), 
3.89 (ddd, J = 14.4, 5.4, 1.2 Hz, 1H), 3.61 (s, 3H), 3.09 (ddd, J = 
14.5, 12.2, 3.9 Hz, 1H), 2.48 (ddd, J = 14.5, 12.2, 5.4 Hz, 1H), 
2.22 (dd, J = 14.5, 2.8 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 
oC) δ 168.1, 146.0, 126.9, 125.2, 124.2, 109.8, 83.4, 72.5, 71.3, 
62.7, 59.3, 37.3, 36.3. IR (CHCl3) ν 1746, 1192, 1045 cm–1. 
HRMS (ESI): calcd for [C13H15NO4S + Na]+ 304.0619, found 
304.0614. 
Tricyclic Acetal (+)-12c. From 104 mg (0.31 mmol) of 
alkynyldioxolane (+)-4d, and after chromatography of the residue 
using hexanes/ethyl acetate (1:2) as eluent gave the acetal (+)-
12c (48 mg, 52%) as a pale yellow oil. [α]D = +4.1 (c 1.0, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.45 (m, 2H), 7.33 
(m, 3H), 4.71 (d, J = 5.1 Hz, 1H), 4.54 and 3.75 (d, J = 4.5 Hz, 
each 1H), 4.28 (dd, J = 8.1, 5.1 Hz, 1H), 4.09 (d, J = 8.1 Hz, 
1H), 3.85 (dd, J = 14.5, 5.2 Hz, 1H), 3.63 (s, 3H), 3.04 (ddd, J = 
14.5, 12.2, 3.7 Hz, 1H), 2.48 (ddd, J = 14.5, 12.3, 5.3 Hz, 1H), 
2.20 (dd, J = 14.5, 2.5 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 
oC) δ 168.0, 131.9, 128.9, 128.2, 121.5, 104.8, 86.4, 84.2, 83.5, 
72.3, 71.6, 62.6, 59.3, 38.7, 35.9. IR (CHCl3) ν 1745, 1195, 1040 
cm–1. HRMS (ESI): calcd for [C17H17NO4 + Na]+ 322.1055, found 
322.1050. 
Tricyclic Acetal (+)-12d. From 90 mg (0.36 mmol) of 
alkynyldioxolane (+)-4e, and after chromatography of the residue 
using hexanes/ethyl acetate (1:2) as eluent gave the acetal (+)-
12d (48 mg, 63%) as a colorless solid. M.p. 132–134ºC. [α]D = 
+5.6 (c 3.3, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 4.55 
(d, J = 5.4 Hz), 4.49 (d, J = 4.6 Hz), 4.08 (dd, J = 7.9, 5.6 Hz, 
1H), 3.95 (m, 1H), 3.74 (ddd, J = 14.5, 5.3, 1.3 Hz, 1H), 3.68 (d, 
J = 4.6 Hz, 1H), 3.60 (s, 3H), 2.93 (ddd, J = 14.5, 12.4, 3.6 Hz, 
1H), 2.10 (ddd, J = 14.4, 12.4, 5.4 Hz, 1H), 1.75 (ddd, J = 14.2, 
3.7, 1.3 Hz, 1H), 1.44 (s, 3H). 13C NMR (75 MHz, CDCl3, 25 oC) 
δ 168.2, 111.9, 83.5, 71.9, 70.7, 62.7, 59.4, 37.2, 36.4, 26.5. IR 
(CHCl3) ν 1746, 1192, 1042 cm–1. HRMS (ESI): calcd for 
[C10H14NO4 + H]+ 214.1079, found 214.1085. 
Tricyclic ketal (+)-13c. From 107 mg (0.35 mmol) of 
alkynyldiol (+)-2c, and after chromatography of the residue using 
hexanes/ethyl acetate (2:1) as eluent gave the acetal (+)-13c (71 
mg, 62%) as a colorless oil. [α]D = +7.7 (c 0.6, CHCl3). 1H NMR 
(300 MHz, CDCl3, 25 oC) δ 7.31 and 6.89 (d, J = 9.0 Hz, each 
2H), 5.05 (m, 1H), 4.96 (d, J = 4.5 Hz, 1H), 4.50 (dd, J = 7.7, 3.7 
Hz, 1H), 4.43 (t, J = 4.7 Hz, 1H), 4.00 (m, 1H), 3.95 and 3.54 (d, 
J = 12.4 Hz, each 1H), 3.80 (s, 3H), 1.69 (q, J = 7.4 Hz, 2H), 
0.97 (t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 
161.7, 156.8, 130.0, 118.2, 114.7, 111.9, 83.6, 77.3, 73.0, 65.9, 
59.3, 55.5, 26.7, 6.8. IR (CHCl3) ν 1744, 1192, 1041 cm–1. 
HRMS (ESI): calcd for [C16H19NO5 + H]+ 306.1341, found 
306.1348. 
Tricyclic acetal (–)-15b. From 58 mg (0.17 mmol) of 
alkynyldioxolane (+)-6b, and after chromatography of the residue 
using hexanes/ethyl acetate (2:1) as eluent gave the acetal (–)-
15b (32 mg, 63%) as a pale yellow oil. [α]D = –1.8 (c 1.3, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.44 (m, 2H), 7.35 
(m, 3H), 5.08 (dd, J = 4.5, 1.2 Hz, 1H), 4.98 (d, J = 4.2 Hz, 1H), 
4.77 and 4.66 (d, J = 16.1 Hz, each 1H), 3.81 (m, 3H), 3.60 (d, J 
= 4.5 Hz, 1H), 2.99 (dt, J = 13.0 Hz, 1H), 1.52 (s, 3H). 13C NMR 
(75 MHz, CDCl3, 25 oC) δ 173.5, 131.7, 128.9, 128.4, 122.0, 
104.3, 87.6, 84.0, 81.3, 71.3, 69.0, 59.6, 56.0, 51.6, 22.9. IR 
(CHCl3) ν 1752, 1190, 1044 cm–1. HRMS (ESI): calcd for 
[C17H17NO4 + H]+ 300.1236, found 300.1215. 
Tricyclic acetal (+)-17. From 85 mg (0.20 mmol) of 
alkynyldioxolane (+)-6c, and after chromatography of the residue 
using hexanes/ethyl acetate (2:1) as eluent gave the acetal (+)-17 
(35 mg, 48%) as a colorless oil. [α]D = +0.3 (c 0.7, CHCl3). 1H 
NMR (300 MHz, CDCl3, 25 oC) δ 8.12 (m, 1H), 7.51 (m, 4H), 
7.32 (m, 5H), 5.01 (d, J = 4.5 Hz, 1H), 4.89 (d, J = 4.7 Hz, 1H), 
4.77 and 4.66 (d, J = 16.1 Hz, each 1H), 4.03 (m, 2H), 3.91 and 
3.13 (m, each 1H), 3.88 (d, J = 4.5 Hz, 1H), 2.37 (m, 1H), 1.96 
(dd, J = 14.3, 2.6 Hz, 1H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 
168.0, 142.5, 131.7, 130.2, 128.8, 128.5, 128.4, 128.3, 128.2, 
128.1, 111.8, 87.4, 84.3, 81.0, 72.5, 71.2, 63.5, 59.6, 38.6, 36.7. 
IR (CHCl3) ν 1746, 1191, 1038 cm–1. HRMS (ESI): calcd for 
[C23H21NO4]+ 375.1471, found 375.1457. 
Metal/acid co-catalyzed cyclization of alkynyldioxolane (+)-4a 
in the absence of water. Preparation of bridged acetal (–)-10 
and ketone (+)-11. From 70 mg (0.29 mmol) of 
alkynyldioxolane (+)-4a, and after chromatography of the residue 
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using hexanes/ethyl acetate (1:1) as eluent, 18 mg (31%) of 
the less polar compound (–)-10 and 20 mg (27%) of the more 
polar compound (+)-11 were obtained. 
Ketone (+)-11. Yellow oil. [α]D = +8.5 (c 0.8, CHCl3). 1H NMR 
(300 MHz, CDCl3, 25 oC) δ 4.58 (d, J = 5.1 Hz, 1H), 4.30 (m, 
2H), 4.09 (m, 2H), 3.85 (dd, J = 9.3, 5.1 Hz, 1H), 3.65 (m, 1H), 
3.55 (s, 3H), 2.15 (s, 3H), 1.36 and 1.31 (s, each 3H). 13C NMR 
(75 MHz, CDCl3, 25 oC) δ 201.6, 167.9, 109.5, 83.3, 76.7, 66.6, 
60.6, 59.2, 50.4, 27.2, 26.8, 25.1. IR (CHCl3) ν 1743, 1715 cm–1. 
HRMS (ESI): calcd for [C12H19NO5]+ 257.1263, found 257.1259. 
General procedure for the metal/acid co-catalyzed cyclization 
of alkynyldiols 1–3. Preparation of bridged acetals 10, and 
12–18. [AuClPPh3] (0.0093 mmol), AgOTf (0.0093 mmol), and 
p-toluenesulfonic acid (0.037 mmol) were sequentially added to a 
stirred solution of the corresponding alkynyldiols 1–3 (0.37 
mmol) in dichloromethane (0.37 mL). The resulting mixture was 
stirred at room temperature until disappearance of the starting 
material (TLC), before being filtered through a pack of celite. 
The filtrate was extracted with ethyl acetate (3 x 5 mL), and the 
combined extracts were washed twice with brine. The organic 
layer was dried (MgSO4) and concentrated under reduced 
pressure. Chromatography of the residue eluting with ethyl 
acetate/hexanes mixtures gave analytically pure adducts 10, and 
12–18. 
Tricyclic acetal (+)-13a. From 61 mg (0.21 mmol) of alkynyldiol 
(+)-2a, and after chromatography of the residue using 
hexanes/ethyl acetate (1:1) as eluent gave the acetal (+)-13a (40 
mg, 63%) as a yellow solid. M.p. 128–130ºC. [α]D = +13.0 (c 0.9, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.31 and 6.89 (d, J 
= 9.0 Hz, each 2H), 5.04 (m, 1H), 4.95 (d, J = 4.4 Hz, 1H), 4.51 
(dd, J = 7.6, 3.7 Hz, 1H), 4.42 (t, J = 4.6 Hz, 1H), 4.03 (m, 1H), 
3.94 (d, J = 12.5 Hz, 1H), 3.80 (s, 3H), 3.54 (dd, J = 12.4, 0.7 Hz, 
1H), 1.41 (s, 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 161.6, 
156.8, 130.5, 118.2, 114.7, 110.3, 83.5, 77.8, 73.0, 65.9, 59.3, 
55.5, 20.5. IR (CHCl3) ν 1747, 1188, 1038 cm–1. HRMS (ESI): 
calcd for [C15H17NO5 + Na]+ 314.1004, found 314.0999. 
Tricyclic acetal (+)-13b. From 114 mg (0.31 mmol) of 
alkynyldiol (+)-2b, and after chromatography of the residue 
using hexanes/ethyl acetate (2:1) as eluent gave the acetal (+)-
13b (74 mg, 60%) as a colorless oil. [α]D = +3.9 (c 1.4, CHCl3). 
1H NMR (300 MHz, CDCl3, 25 oC) δ 7.28 (m, 7H), 6.87 (d, J = 
9.0 Hz, 2H), 5.00 (m, 1H), 4.90 (d, J = 4.6 Hz, 1H), 4.47 (dd, J = 
7.6, 3.7 Hz, 1H), 4.40 (t, J = 4.6 Hz, 1H), 3.99 and 3.49 (d, J = 
12.2 Hz, each 1H), 3.91 (m, 1H), 3.79 (s, 3H), 3.00 (d, J = 1.8 
Hz, 2H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 161.6, 156.8, 
134.7, 130.3, 128.8, 128.2, 118.1, 114.7, 111.0, 83.5, 77.2, 73.1, 
65.7, 59.2, 55.5, 40.8. IR (CHCl3) ν 1745, 1190, 1040 cm–1. 
HRMS (ESI): calcd for [C21H21NO5 + Na]+ 390.1317, found 
390.1311. 
Metal/acid co-catalyzed cyclization of bis(alkynyl)dioxolane 
(+)-6a in the presence of water. Preparation of bridged 
acetals (–)-14, (–)-15a, and (+)-16a. From 65 mg (0.25 mmol) of 
bis(alkynyl)dioxolane (+)-6a, and after chromatography of the 
residue using hexanes/ethyl acetate (2:1) as eluent, 16 mg (29%) 
of the less polar compound (–)-15a, 22 mg (36%) of compound 
(–)-14, and 16 mg (27%) of the more polar compound (+)-16a 
were obtained. 
Tricyclic Acetal (–)-14. Pale yellow oil. [α]D = –0.4 (c 0.7, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 4.99 (m, 1H), 4.79 
(dd, J = 4.5, 1.2 Hz, 1H), 4.60 and 4.42 (d, J = 17.7 Hz, each 
1H), 3.89 (m, 2H), 3.80 and 2.99 (d, J = 13.0 Hz, each 1H), 3.60 
(d, J = 4.7 Hz, 1H), 2.16 (s, 3H), 1.51 (s, 3H). 13C NMR (75 
MHz, CDCl3, 25 oC) δ 205.3, 173.3, 104.4, 82.9, 77.2, 71.2, 69.1, 
56.0, 51.6, 26.1, 23.0. IR (CHCl3) ν 1747, 1710, 1195, 1044 cm–
1. HRMS (ESI): calcd for [C11H15NO5 + H]+ 242.1028, found 
242.1023. 
Tricyclic Acetal (–)-15a. Colorless oil. [α]D = –1.2 (c 0.5, 
CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 5.00 (dd, J = 4.5, 
1.0 Hz, 1H), 4.90 (d, J = 4.1 Hz, 1H), 4.56 and 4.46 (dd, J = 16.1, 
2.5 Hz, each 1H), 3.85 (m, 2H), 3.81 and 2.99 (d, J = 13.0 Hz, 
each 1H), 3.58 (d, J = 4.5 Hz, 1H), 2.51 (t, J = 2.3 Hz, 1H), 1.51 
(s, 3H). 13C NMR (75 MHz, CDCl3, 25 oC) δ 173.3, 104.3, 81.1, 
78.7, 75.8, 71.2, 69.0, 58.7, 55.8, 51.6, 22.9. IR (CHCl3) ν 3315, 
1745, 1192, 1045 cm–1. HRMS (ESI): calcd for [C11H13NO4 + H]+ 
224.0923, found 224.0919. 
Tricyclic Acetal (+)-16a. Colorless solid. M.p. 150–152ºC. [α]D 
= +6.6 (c 0.9, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 4.91 
(d, J = 4.4 Hz, 1H), 4.67 (m, 1H), 4.32 and 3.91 (d, J = 18.8 Hz, 
each 1H), 4.23 (m, 1H), 4.06 (t, J = 4.4 Hz, 1H), 3.89 and 3.47 
(d, J = 12.5 Hz, each 1H), 2.15 (s, 3H), 1.37 (s, 3H). 13C NMR 
(75 MHz, CDCl3, 25 oC) δ 201.5, 165.6, 110.0, 84.7, 78.1, 74.1, 
66.8, 61.4, 50.8, 27.3, 20.6. IR (CHCl3) ν 1747, 1712, 1192, 1042 
cm–1. HRMS (ESI): calcd for [C11H15NO5]+ 241.0950, found 
241.0937. 
Metal/acid co-catalyzed cyclization of bis(alkynyl)dioxolane 
(+)-6d in the presence of water. Preparation of bridged 
acetals (+)-16b and (+)-18. From 32 mg (0.096 mmol) of 
bis(alkynyl)dioxolane (+)-6d, and after chromatography of the 
residue using hexanes/ethyl acetate (1:1) as eluent, 11 mg (37%) 
of the less polar compound (+)-18 and 16 mg (52%) of the more 
polar compound (+)-16b were obtained. 
Tricyclic Acetal (+)-16b. Colorless solid. M.p. 123–125ºC. [α]D 
= +2.7 (c 1.5, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.95 
(m, 2H), 7.62 (m, 1H), 7.54 (m, 2H), 4.92 (m, 1H), 4.23 (d, J = 
4.4 Hz, 1H), 4.37 (dd, J = 7.5, 3.6 Hz, 1H), 4.01 (t, J = 4.4 Hz, 
1H), 3.92 (dd, J = 16.4, 7.5 Hz, 1H), 3.84 and 3.43 (d, J = 12.6 
Hz, each 1H), 3.63 (m, 2H), 3.30 (m, 2H), 1.36 (s, 3H). 13C NMR 
(75 MHz, CDCl3, 25 oC) δ 197.5, 165.5, 135.9, 133.8, 128.8, 
128.0, 110.0, 84.1, 77.8, 73.6, 65.9, 61.0, 37.2, 36.3, 20.6. IR 
(CHCl3) ν 1743, 1705, 1190, 1040 cm–1. HRMS (ESI): calcd for 
[C17H19NO5]+ 317.1263, found 317.1249. 
Tricyclic Acetal (+)-18. Colorless solid. M.p. 153–155ºC. [α]D = 
+11.6 (c 0.8, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 7.37 
(m, 5H), 4.96 (m, 1H), 4.87 (d, J = 4.2 Hz, 1H), 4.63 (dd, J = 7.7, 
3.6 Hz, 1H), 4.51 and 4.06 (d, J = 17.8 Hz, each 1H), 4.10 (m, 
2H), 3.89 and 3.47 (d, J = 12.6 Hz, each 1H), 1.37 (s, 3H). 13C 
NMR (75 MHz, CDCl3, 25 oC) δ 163.9, 131.6, 129.0, 128.5, 
121.6, 110.2, 85.1, 84.7, 81.4, 77.8, 73.6, 66.2, 60.1, 31.7, 20.6. 
IR (CHCl3) ν 2225, 1745, 1190, 1042 cm–1. HRMS (ESI): calcd 
for [C17H17NO4 + H]+ 300.1236, found 300.1230. 
Procedure for the metal/acid co-catalyzed cyclization of 
alkynyldioxolane (+)-4b using D2O instead of H2O. 
Preparation of fused acetal (+)-[D]-12a. [AuClPPh3] (0.0063 
mmol), AgOTf (0.0063 mmol), p-toluenesulfonic acid, and 
deuterium oxide (0.50 mmol) were sequentially added to a stirred 
solution of the alkynyldioxolane (+)-4b (78 mg, 0.25 mmol) in 
dichloromethane (0.25 mL). The resulting mixture was heated in 
a sealed tube at 80 oC for 3 h. The reaction was allowed to cool to 
room temperature and filtered through a pack of celite. The 
filtrate was extracted with ethyl acetate (3 x 5 mL), and the 
combined extracts were washed twice with brine. The organic 
layer was dried (MgSO4) and concentrated under reduced 
pressure. Chromatography of the residue eluting with 
hexanes/ethyl acetate (1:2) gave 51 mg (65%) of analytically 
pure adduct (+)-[D]-12a; as a colorless solid. M.p. 160–162ºC. 
[α]D = +7.9 (c 0.9, CHCl3). 1H NMR (300 MHz, CDCl3, 25 oC) δ 
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7.57 (m, 2H), 7.32 (m, 3H), 4.67 (d, J = 4.9 Hz, 1H), 4.57 (d, J = 
4.7 Hz, 1H), 3.87 (ddd, J = 14.4, 5.4, 1.5 Hz, 1H), 3.79 (d, J = 
4.6 Hz, 1H), 3.63 (s, 3H), 4.05 (m, 2H), 3.87 and 3.10 (d, J = 
14.4 Hz, each 1H), 3.80 (d, J = 4.7 Hz, 1H), 3.64 (s, 3H). 13C 
NMR (75 MHz, CDCl3, 25 oC) δ 167.7, 142.0, 127.7, 127.6, 
124.3, 111.2, 83.0, 71.8, 70.8, 62.5, 58.8, 36.0 (m). IR (CHCl3) ν 
1749, 1190, 1045 cm–1. HRMS (ESI): calcd for [C15H15D2NO4 + 
Na]+ 300.1181, found 300.1175. 
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